Caris Life Sciences at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Caris Life Sciences brings 2 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 1215. The molecular profiling company presents a proteogenomic tumor antigen found in patient tissue and a multi-biomarker predictor of benefit from CDK4/6 inhibitors in metastatic disease.

OrganizationSABCS 2026 Attendance
Diagnostics
Molecular profiling company whose tissue and blood tests, backed by AI, map a tumor's DNA, RNA and proteins to guide cancer treatment.
Booth
Exhibiting at Booth 1215
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
12:30–2pm
Patient-tissue proteogenomics identifies a novel cell-surface tumor antigen as a treatment-retained ADC target in breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Thu Dec 10
5–6:30pm
Development of a multi-biomarker predictor of CDK4/6 inhibitor benefit in metastatic breast cancer
Exhibit Hall
Breast Cancer: Metastatic - Hormone Receptor Positive

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Caris Life Sciences

Tell us what you sell and we’ll find the people at Caris Life Sciences most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction